IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

Key Terms

data-as-a-service (daas+) technical

Data-as-a-service (DaaS+) is a subscription model where a company collects, cleans and delivers ready-to-use data and enhanced insights over the internet, often adding analytics, real-time updates or machine-learning enhancements. For investors, it matters because DaaS+ products can create steady recurring revenue, scale without proportional costs, and build customer lock-in like a utility, while also carrying risks from data quality, regulation and competitive edge.

cloud infrastructure technical

Cloud infrastructure is the network of remote servers, storage, networking and basic software that companies rent over the internet instead of owning their own physical data centers — like using a utility grid or renting a fully equipped office rather than buying a building and furniture. Investors care because it changes how a company spends money, scales operations, launches products and manages risk: it can lower upfront costs, speed growth, concentrate vendor or outage risk, and influence recurring revenue and margins.

analytics technical

Analytics involves examining data to identify patterns, trends, and insights that can inform decision-making. For investors, it’s like using a detailed weather forecast to plan for the future—helping them understand potential risks and opportunities. By turning raw information into understandable information, analytics supports smarter, more informed choices in financial activities.

ai powered analytics technical

AI-powered analytics uses computer programs that learn from data to find patterns, make forecasts and turn complex numbers into clear, actionable insights. For investors, this is like having a fast, tireless research assistant that can spot trends, flag risks and surface opportunities across large amounts of information—potentially improving decision speed and accuracy, though results still depend on data quality and the assumptions behind the models.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic long-term collaboration with Boehringer Ingelheim. Boehringer Ingelheim has selected IQVIA’s Data-as-a-Service (DaaS+) technology offering as the accelerator to power its global commercial data harmonization and transformation journey.

This collaboration will enable Boehringer Ingelheim to scale its commercial data products and analytics ambitions across therapeutic areas and regional teams, leveraging an industry-leading global data model.

“We are excited about the possibilities of working with IQVIA’s Data as a Service (DaaS+) platform. By enabling the seamless ingestion of our global commercial data sets into a unified platform, directly integrated into our cloud infrastructure, we believe this platform would drive significant efficiencies in our data operations, including affording advanced analytics and innovative use cases, paving the way for transformative insights and decision-making,” said Justin Gale, Global Head of Data Excellence at Boehringer Ingelheim.

The collaboration supports upcoming launches and enhances existing market performance, providing harmonized data for all market, brand and franchise reporting across 59 countries. Boehringer will benefit from global product mastering, efficient data management and seamless access to IQVIA data for data-driven decision making.

“Through this strategic collaboration, Boehringer Ingelheim will be able to harness IQVIA’s innovative solution to enable the creation of a global data foundation that will help drive faster, data-informed decision-making across its business, and accelerate the path towards an AI powered analytics future,” said Tom Baker, Senior Vice President, Global Data, Technologies and Advisory Services (DTAS).

For more information, visit www.iqvia.com.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions is powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI^®, advanced analytics, the latest technologies, and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance, and patient safety, and delivering AI to the high standards of trust, scalability, and precision demanded by the industry. With approximately 91,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

About Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at https://www.boehringer-ingelheim.com.

IQVIAFIN

View source version on businesswire.com: https://www.businesswire.com/news/home/20260129755415/en/

Investor Relations:

Kerri Joseph, IQVIA

kerri.joseph@iqvia.com

+1.973.541.3558

Media Relations:

Alissa Maupin, IQVIA

alissa.maupin1@iqvia.com

+1.919.923.6785

Source: IQVIA